Bulls Keep Del Fris...
Health Care: Drugs
ZIOPHARM Oncology Inc. (ZIOP: NASDAQ)
$1.67 -0.09 | -5.11%
05/17/13 - 04:00 PM ET
822.64K / 2.05M
Vol / Avg. Vol:1.78 / 1.76
Open / Prev. Close:1.67 - 1.82
Today's Range:1.49 - 6.33
52 Wk Range:-57.69%
Performance YTD:TheStreet Rating:
Portfolios with ZIOP
- Portfolio NameUser Type
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- Contributor22 Biopharma Stocks With Br...
- UserTurnbull STAR
- UserStock Game
- ContributorStocks With Big Insider Buy...
- Contributor13 Biotech Stocks Bought an...
- ContributorStocks With Big Insider Buy...
- UserASCO 2010
Latest ZIOP Headlines from TheStreet
- 5 Stocks Seeing Bullish Options Action 05.16.13 | 10:05 am
- 5 Stocks Under $10 Set to Soar 05.16.13 | 07:05 am
- ZIOPHARM Announces Presentation Of Promising Nonclinical And Phase I Study Results Of Ad-RTS-IL-12 In Advanced Melanoma At ASGCT 16th Annual Meeting 05.16.13 | 07:05 am
- ZIOPHARM Announces Poster Presentation At The 2013 American Society For Clinical Oncology (ASCO) Annual Meeting 05.15.13 | 06:05 pm
- ZIOPHARM Announces First Quarter Financial Results And Key Developments 05.07.13 | 04:05 pm
- Leaders of TheStreet's Drug Approval Contest 05.06.13 | 09:05 am
- 4 Biotech Stocks Under $10 Making Big Moves 04.09.13 | 02:04 pm
- ZIOPHARM Presents Preclinical Data Supporting DNA-Based IL-12 Therapy For Breast Cancer 04.09.13 | 08:04 am
- 3 Volatile Drug Stocks To Watch 04.01.13 | 03:04 pm
- Ziopharm Considers Options After Drug Failure 03.27.13 | 11:03 am
Press Releases for ZIOP
- ZIOPHARM Oncology To Present At The 30th Annual J.P. Morgan Healthcare Conference - Business Wire 12.21.11 | 06:12 am
- ZIOPHARM Oncology To Present At The Oppenheimer 22nd Annual Healthcare Conference - Business Wire 12.08.11 | 06:12 am
- ZIOPHARM Granted European Patent Allowance For Palifosfamide - Business Wire 12.07.11 | 06:12 am
- ZIOPHARM Oncology To Present At The 23rd Annual Piper Jaffray Health Care Conference - Business Wire 11.22.11 | 06:11 am
- Preclinical Darinaparsin Study In PLoS ONE Publication - Business Wire 11.21.11 | 06:11 am
- ZIOPHARM Oncology Presents New Darinaparsin Preclinical Prostate And Pancreatic Cancer Data At AACR-NCI-EORTC Meeting - Business Wire 11.15.11 | 03:11 pm
- ZIOPHARM Oncology Announces Promising Data From Phase 1b Study Of Palifosfamide In Small Cell Lung And Other Cancers At AACR-NCI-EORTC Meeting - Business Wire 11.14.11 | 03:11 pm
- ZIOPHARM Oncology Presents Preclinical Data For Darinaparsin Effect On Hedgehog Signaling Pathway In Prostate Cancer At AACR-NCI-EORTC Meeting - Business Wire 11.13.11 | 03:11 pm
- ZIOPHARM Oncology To Present At The Lazard Capital Markets 8th Annual Healthcare Conference - Business Wire 11.09.11 | 06:11 am
- ZIOPHARM Reports Third Quarter Financial Results And Highlights - Business Wire 11.03.11 | 04:11 pm
Partner Headlines for ZIOP
- Will Ziopharm’s Positive Tests Impress These Top Institutional Shareholders? - Wall St. Cheat Sheet 04.09.13 | 01:04 pm
- 3 Biotechs And The Feuerstein-Ratain Rule - Seeking Alpha 04.09.13 | 09:04 am
- Today's Market News To Trade On: 5 Stocks Moving On News - Seeking Alpha 03.27.13 | 09:03 am
- Threshold Pharmaceuticals - A Derivative Trade On Ziopharm's Upcoming Data - Seeking Alpha 03.22.13 | 09:03 am
- Mid-Week Biopharma Catalyst Trades To Consider - Seeking Alpha 12.13.12 | 09:12 am
- Ziopharm: Key Oncology Catalyst Approaching - Seeking Alpha 12.10.12 | 09:12 am
- ZIOPHARM Oncology Completes Enrollment in PICASSO 3 Trial - Benzinga 06.02.12 | 10:06 am
- 5 Reasons To Buy Ziopharm - Seeking Alpha 03.16.12 | 09:03 am
- 5 Small Cap Health Services Stocks To Watch - Seeking Alpha 02.14.12 | 08:02 am
- Cramer's Mad Money - 10 Earnings Reports To Watch This Week (2/10/12) - Seeking Alpha 02.12.12 | 07:02 am
